Antibodies to cardiolipin (aCL) are part of a family of autoantibodies directed against cell membrane phospholipids. These antibodies have assumed importance in the past decade because their presence in some patients, especially those with systemic lupus erythematosus (SLE), has been associated with venous and arterial thrombosis, cerebral disease, recurrent fetal loss, and thrombocytopenia.
In Malaysia SLE is common and found more often among the Chinese than the Indian or indigenous Malay populations.5 6 Thus ethnic factors seem to have an influence on the susceptibility to the disease.
We wondered whether levels of aCL are affected in patients with lupus from Malaysia by the ethnic or environmental background or reflect the clinical manifestations of the disease. Using a standardised enzyme linked immunosorbent assay (ELISA),7 8 (table 3) .
No differences were found in the prevalences of raised aCL between the three ethnic groups and no association was noted between aCL Table 2 Median and ranges of anticardiolipin antibody In this study no differences in disease manifestations among patients belonging to different racial groups were noted. Of interest, however, is the observation that renal disease was present in over 70% of cases, a prevalence much higher than those reported in other series, which ranged from 19-6 to 50-0%. 9 10 This finding confirms a previous observation by Wang et al," who noted that patients with lupus in Malaysia commonly have renal disease and a more severe form of membranous lupus nephritis than Western patients. In contrast with the prevalence of renal disease, thrombosis was extremely rare in our patients. This might be due to a bias in referral: thus patients with lupus presenting with thrombotic episodes might have been preferentially referred to non-SLE clinics. The clinical history of even our longstanding patients was consistently negative for thrombotic episodes, however, indicating that the low prevalence of thrombosis in our patients was genuinely an uncommon phenomenon.
It has been suggested that thrombotic manifestations in SLE are provoked by increased levels of antiphospholipid antibodies, especially aCL and 'lupus anticoagulant' antibody.2 Of importance, therefore, is the observation that our patients had raised levels of aCL in their sera only occasionally, the antibody being present above normal in 16 The first study showed that aCL was present in only 27% of Indian lupus patients, in whom thrombosis was also rare, and the second study found aCL in just 20% of cases in Brazil. Two further reports from South Africa show that although clinical characteristics of SLE in the black population do not differ from those described in series from other parts of the world, the prevalence of aCL is low. 9 20 These findings further indicate that regional determinants, be they environmental or genetic, have an important role in governing aCL production.
In our series we did not find the reported correlation between aCL and cerebral disease,2' possibly because this complication results from levels of aCL higher than those found in our study. On the other hand, we confirmed that levels of aCL correlate positively with age22-24 and negatively with the platelet count.3 25 The link between recurrent abortion and aCL3 was also supported by our findings as women with recurrent abortions had the highest levels of aCL.
Support for the notion that aCL causes disease is provided by two facts illustrated in this study. Firstly, the uniquely low occurrence of thrombosis in our patients with lupus was associated with the lowest prevalence of aCL yet reported in the disease. Secondly, the highest aCL levels were found in patients with thrombocytopenia. Moreover, it is becoming clear that autoantibodies are of two major immunoglobulin isotypes: IgG and IgM.26 Whereas IgM autoantibodies have low affinity, broad reactivity, and low damaging capacity, IgG autoantibodies have high affinity and specificity for their antigen and high damaging potential. 26 In view of this the finding that aCL belongs predominantly to the IgG isotype may also be of pathogenic relevance.
In summary, the unexpected findings of absence of thrombosis and rarity of anticardiolipin antibodies in patients from Malaysia with lupus reinforce the association of the two and suggest an influence of regional factors on the manifestations of SLE. 
